Libbs Farmacêutica made a US$1m investment in Brazilian biotech PluriCell to develop regenerative cell therapies for cardiovascular diseases. PluriCell was founded in 2013 and incubated at USP/IPEN-Cietec. (Istoé Dinheiro) As…
Libbs Farmacêutica made a US$1m investment in Brazilian biotech PluriCell to develop regenerative cell therapies for cardiovascular diseases. PluriCell was founded in 2013 and incubated at USP/IPEN-Cietec. (Istoé Dinheiro) As…